Xometry price target raised to $40 from $35 at UBS

UBS raised the firm’s price target on Xometry (XMTR) to $40 from $35 and keeps a Neutral rating on the shares. Revenue, gross margin, and EBITDA all came in ahead of expectations in Q2 despite a still uncertain macro backdrop, the analyst tells investors in a research note. While Xometry embedded some growth moderation in the second half due to macro conservatism, July is said to be off to a strong start and growth momentum remains strong, UBS says.